We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Miss
Jeannie
McKie
j.mckie@nhs.net
Dr
Jaime
Delgadillo
j.delgadillo@sheffield.ac.uk
Jeannie
McKie
rdash.research-gov@nhs.net
Uplift-X
Trial Team
rdash.upliftx@nhs.net
Mood [affective] disordersNeurotic, stress-related and somatoform disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Mental health problems are common and affect around one in six adults. Most countries lack sufficient mental health provision to meet the needs of people with common mental disorders (CMD). Four developments in the psychotherapy field have the potential to address the shortfalls in access and effectiveness of treatment; 1) efficient group-based psychological therapy, 2) effective ‘transdiagnostic’ interventions relevant for a wide variety of CMDs, 3) accessible internet-delivered digital psychological interventions and 4) personalised treatment tailored for each patient. UpLift-X is a research programme than aims to integrate all these four advances into a single and comprehensive digital health platform, which we expect will be a cost-effective solution to maximize access to highly effective treatment for a large population of patients with CMDs. The overall aim of this study is to test the effectiveness of a modularised, transdiagnostic, digitally-enabled 12-session group intervention for the treatment of CMD, based on the Unified Protocol (UP) for the treatment of emotional disorders. The therapy will be accessed on a digital platform which will include helpful videos and information about coping skills. Funded by Innovate UK, a pragmatic, multi-site, factorial cluster randomised controlled trial will recruit patients accessing NHS Talking Therapies treatment for CMDs. The trial will evaluate if altering the sequence of UP therapy modules affects clinical outcomes or drop-out and aim to develop a personalised module selection method to tailor treatment to the needs of patients with a wide range of clinical problems. The study will also evaluate the clinical and cost-effectiveness of digitally-enabled group therapy compared to individual Cognitive Behavioural Therapy (current standard treatment).
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Psychological & Behavioural;
You can take part if:
You may not be able to take part if:
Age < = 16. Not able to speak or read English fluently, which would require more individualised support with interpreters. No access to internet-connected device or confidential space to engage with digital intervention. Not involved with NHS-Talking Therapies services. Assessed by a qualified psychological professional and not deemed to be eligible for high intensity Cognitive Behavioural Therapy( CBT) on the basis of mental health condition and/or risk assessment (e.g., acute risk of suicide at the time of assessment). Already accessing a high intensity psychotherapy or other forms of psychological treatment (e.g., private therapy, counselling) Presenting with symptoms of eating disorders, substance use disorders, psychotic disorders, personality disorders, bipolar disorders identified at the time of initial assessment.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Jeannie
McKie
rdash.research-gov@nhs.net
Dr
Jaime
Delgadillo
j.delgadillo@sheffield.ac.uk
Uplift-X
Trial Team
rdash.upliftx@nhs.net
Miss
Jeannie
McKie
j.mckie@nhs.net
The study is sponsored by ROTHERHAM DONCASTER AND SOUTH HUMBER NHS FOUNDATION TRUST and funded by Innovate UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 63638
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
